Movement compensation during carbon dioxide coronary angiography: In-vitro validation
The aim of this in vitro study was to evaluate the feasibility of movement compensation for CO2 coronary angiography. The use of CO2 as a contrast medium for coronary angiography in a routine clinical setting is still premature. Nonetheless, the gas can solve most of the problems related to iodine c...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2018-09-01
|
Series: | AIP Advances |
Online Access: | http://dx.doi.org/10.1063/1.5030796 |
id |
doaj-a825b783d8554c34a718142dfcb67fe2 |
---|---|
record_format |
Article |
spelling |
doaj-a825b783d8554c34a718142dfcb67fe22020-11-25T02:30:52ZengAIP Publishing LLCAIP Advances2158-32262018-09-0189095005095005-710.1063/1.5030796009809ADVMovement compensation during carbon dioxide coronary angiography: In-vitro validationIvan Corazza0Sonia Sapignoli1Pier Luca Rossi2Alessandro Lombi3Edoardo Pirazzini4Nevio Taglieri5James G. Caridi6Romano Zannoli7Experimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyDepartment of Physics and Astronomy, University of Bologna, Viale Berti Pichat 6/2, 40127 Bologna, ItalyDepartment of Physics and Astronomy, University of Bologna, Viale Berti Pichat 6/2, 40127 Bologna, ItalyExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyHealth Sciences Center, Tulane University, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699, USAExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyThe aim of this in vitro study was to evaluate the feasibility of movement compensation for CO2 coronary angiography. The use of CO2 as a contrast medium for coronary angiography in a routine clinical setting is still premature. Nonetheless, the gas can solve most of the problems related to iodine contrast-induced nephropathy and can be safely used for patients with renal insufficiency. In a previous work [I. Corazza et al., AIP Adv. 8(1), 015225 (2018)], we demonstrated that an adequate setting of the CO2 injection parameters (pressures and volumes) allows gas injection into the coronaries, avoiding reflux into the aorta and cerebral circulation. A mechanical mock simulating coronary circulation and movement was used to simulate different CO2 injection conditions. Simultaneous acquisition of ECG and optical images allowed synchronous frame extraction for post-processing analysis, like masking and stacking processes. A single test with a radiological apparatus was done to demonstrate the feasibility of the technique. By injecting CO2 at a pressure between the dicrotic notch and diastolic value, no reflux into the aorta was observed and the new software yielded final optical images of clinical quality after about 8 seconds of injection. The feasibility test under the X-ray apparatus gave promising results. CO2 coronary angiography is still far from becoming a clinical standard, but our bench evaluation demonstrates that if the injection parameters are well-controlled and physiological values known, CO2 can be used as a contrast agent not only for the lower part of the body, but also for the coronary arteries, respecting basic safety standards.http://dx.doi.org/10.1063/1.5030796 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ivan Corazza Sonia Sapignoli Pier Luca Rossi Alessandro Lombi Edoardo Pirazzini Nevio Taglieri James G. Caridi Romano Zannoli |
spellingShingle |
Ivan Corazza Sonia Sapignoli Pier Luca Rossi Alessandro Lombi Edoardo Pirazzini Nevio Taglieri James G. Caridi Romano Zannoli Movement compensation during carbon dioxide coronary angiography: In-vitro validation AIP Advances |
author_facet |
Ivan Corazza Sonia Sapignoli Pier Luca Rossi Alessandro Lombi Edoardo Pirazzini Nevio Taglieri James G. Caridi Romano Zannoli |
author_sort |
Ivan Corazza |
title |
Movement compensation during carbon dioxide coronary angiography: In-vitro validation |
title_short |
Movement compensation during carbon dioxide coronary angiography: In-vitro validation |
title_full |
Movement compensation during carbon dioxide coronary angiography: In-vitro validation |
title_fullStr |
Movement compensation during carbon dioxide coronary angiography: In-vitro validation |
title_full_unstemmed |
Movement compensation during carbon dioxide coronary angiography: In-vitro validation |
title_sort |
movement compensation during carbon dioxide coronary angiography: in-vitro validation |
publisher |
AIP Publishing LLC |
series |
AIP Advances |
issn |
2158-3226 |
publishDate |
2018-09-01 |
description |
The aim of this in vitro study was to evaluate the feasibility of movement compensation for CO2 coronary angiography. The use of CO2 as a contrast medium for coronary angiography in a routine clinical setting is still premature. Nonetheless, the gas can solve most of the problems related to iodine contrast-induced nephropathy and can be safely used for patients with renal insufficiency. In a previous work [I. Corazza et al., AIP Adv. 8(1), 015225 (2018)], we demonstrated that an adequate setting of the CO2 injection parameters (pressures and volumes) allows gas injection into the coronaries, avoiding reflux into the aorta and cerebral circulation. A mechanical mock simulating coronary circulation and movement was used to simulate different CO2 injection conditions. Simultaneous acquisition of ECG and optical images allowed synchronous frame extraction for post-processing analysis, like masking and stacking processes. A single test with a radiological apparatus was done to demonstrate the feasibility of the technique. By injecting CO2 at a pressure between the dicrotic notch and diastolic value, no reflux into the aorta was observed and the new software yielded final optical images of clinical quality after about 8 seconds of injection. The feasibility test under the X-ray apparatus gave promising results. CO2 coronary angiography is still far from becoming a clinical standard, but our bench evaluation demonstrates that if the injection parameters are well-controlled and physiological values known, CO2 can be used as a contrast agent not only for the lower part of the body, but also for the coronary arteries, respecting basic safety standards. |
url |
http://dx.doi.org/10.1063/1.5030796 |
work_keys_str_mv |
AT ivancorazza movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation AT soniasapignoli movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation AT pierlucarossi movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation AT alessandrolombi movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation AT edoardopirazzini movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation AT neviotaglieri movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation AT jamesgcaridi movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation AT romanozannoli movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation |
_version_ |
1724827208944451584 |